(Q28287733)

English

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

scientific article

In more languages

Statements

scholarly article

0 references

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study (English)

0 references

0 references

Alzheimer's disease

1 reference

based on heuristic

inferred from title

Svetlana I. Gavrilova

object named as

Svetlana I Gavrilova

2

0 references

5

object named as

Paul S Aisen

0 references

3

object named as

Mary Sano

0 references

author name string

Rachelle S Doody

1

0 references

Ronald G Thomas

4

0 references

Sergey O Bachurin

6

0 references

Lynn Seely

7

0 references

David Hung

8

0 references

language of work or name

0 references

publication date

19 July 2008

0 references

0 references

372

0 references

9634

0 references

207-15

0 references

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer Disease in the US Population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholinesterase inhibitors for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitochondria as a target for neurotoxins and neuroprotective agents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological verification of ischemic score in differentiation of dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacology and use of H1-receptor-antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Memantine for dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the placebo control obsolete in a world after donepezil and vitamin E?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(08)61074-0

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28287733&oldid=1970706670"